Main Sector
Pharma (fully integrated)
Subsectors
Antibodies
Anti-infectives
Biosimilars
Peptides
Small molecule therapeutics
Vaccines
Molecular diagnostics
Immunotherapy
Indications
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Congenital malformations, deformations and chromosomal abnormalities / medical genetics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Injury, poisoning and certain other consequences of external causes / toxicology
Products
In development: 96
On the market: 38
Description
Johnson & Johnson, commonly known as J&J, is a global healthcare company headquartered in New Brunswick. The company focuses on developing and manufacturing pharmaceuticals, medical technologies, and healthcare solutions. Its operations are organized into two main business segments: Innovative Medicine and MedTech. The company develops treatments and products across areas such as oncology, immunology, neuroscience, cardiovascular disease, surgery, orthopaedics, and vision care. J&J operates...
